Translating science into solutions for individualized patient care
bioTheranostics discovers, develops, and commercializes proprietary molecular-based diagnostic, prognostic, and predictive tests that provide physicians with actionable information to help guide cancer treatment.
Bringing the abstract to the here and now
Extensive research generates high-complexity molecular tools that help physicians execute more informed treatment decisions in clinical practice every day.
Partnering with a range of physicians, from
world-renowned institutions to community clinics.
bioTheranostics brings genomic tools to the fingertips of oncology practices across all clinical settings.
Delivering information for personalized medicine.
Because every patient deserves a customized care plan.
Molecular information helps individualize each patient's treatment.
The only robust, validated tool to help with clinical
decision-making for extended endocrine treatment
- Predictive for likelihood of benefit from extended endocrine therapy
- Prognostic for risk of late distant recurrence
diagnosis and treatment of metastatic cancer
CancerTYPE ID and CancerTREATMENT NGS+